BGI Genomics Co., Ltd. (SHE:300676)

BGI Genomics Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 5, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	19,599	16,005	19,676	21,188	35,990	50,923
Market Cap Growth	43.09%	-18.66%	-7.14%	-41.13%	-29.32%	85.26%
Enterprise Value	16,506	11,837	14,568	14,557	28,800	47,594
Last Close Price	51.06	41.97	47.86	50.67	85.65	125.02
PE Ratio	-	-	211.80	26.39	24.63	24.38
Forward PE	779.91	25.09	25.09	25.09	35.26	24.70
PS Ratio	5.40	4.14	4.52	3.00	5.32	6.06
PB Ratio	2.09	1.73	1.97	2.07	3.81	8.45
P/TBV Ratio	2.21	1.83	2.10	2.20	3.99	8.91
P/FCF Ratio	-	-	-	-	17.20	15.42
P/OCF Ratio	-	167.21	48.14	161.89	14.54	14.14
EV/Sales Ratio	4.55	3.06	3.35	2.06	4.26	5.67
EV/EBITDA Ratio	-	-	30.18	11.53	14.70	16.16
EV/EBIT Ratio	-	-	128.98	16.08	17.14	18.01
EV/FCF Ratio	-20.06	-	-	-	13.76	14.42
Debt / Equity Ratio	0.09	0.05	0.04	0.02	0.09	0.22
Debt / EBITDA Ratio	-	-	0.66	0.15	0.41	0.45
Debt / FCF Ratio	-	-	-	-	0.41	0.40
Asset Turnover	0.28	0.30	0.31	0.49	0.53	0.98
Inventory Turnover	3.92	3.93	3.34	4.42	3.02	5.00
Quick Ratio	2.50	2.14	2.13	2.23	2.94	1.87
Current Ratio	2.81	2.42	2.41	2.47	3.26	2.21
Return on Equity (ROE)	-9.48%	-9.46%	0.93%	8.23%	19.11%	40.32%
Return on Assets (ROA)	-4.05%	-3.52%	0.50%	3.95%	8.25%	19.32%
Return on Capital (ROIC)	-5.02%	-4.58%	0.68%	5.46%	11.91%	27.97%
Return on Capital Employed (ROCE)	-	-	1.10%	8.70%	15.50%	35.80%
Earnings Yield	-4.67%	-5.64%	0.47%	3.79%	4.06%	4.11%
FCF Yield	-4.20%	-2.71%	-4.21%	-5.36%	5.81%	6.48%
Dividend Yield	0.20%	-	0.21%	1.97%	0.41%	0.28%
Payout Ratio	-	-	448.58%	20.82%	12.16%	2.98%
Buyback Yield / Dilution	1.73%	-0.01%	-0.48%	0.32%	-3.11%	0.20%
Total Shareholder Return	1.92%	-0.01%	-0.27%	2.29%	-2.70%	0.48%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.